It's still an unknown as to what location Mediimune have taken the candidates for further evaluation so who knows really ? Pfizer recently moved ahead of Mediimune with stage of agreement yet they actually started 6 months earlier. I do think Cambridge is a viable location however we are only working off assumptions & managements comments in the recent update about negotiations being shaken up through restructuring could easily be applied to both future partnerships in discussion & those underway. Roche's R&D move out of Switzerland is a pretty good example of timelines being bended & projects put on hold right when they were mopving to the pointy end - actually love to know what the frik is happening there aswell - 14 months since last partnerships specific update ?
Anyway all in time i guess.
PYC Price at posting:
3.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)